The optimal organization of gynecologic oncology services: A systematic review

Current Oncology

Volumn 22, Issue 4, 2015, Pages e282-e293

  Fung Kee Fung, M ^a   Kennedy, E B ^b   Biagi, J ^c   Colgan, T ^d   D'Souza D ^e   Elit, L M ^f   Hunter, A ^g   Irish, J ^g   McLeod, R ^g   Rosen, B ^h  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Cancer Centre of Southeastern Ontario   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e Juravinski Cancer Centre and McMaster University ^*  (Canada)

^f JURAVINSKI CANCER CENTRE   (Canada)

^g CANCER CARE ONTARIO   (Canada)

^h PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Gynecologic oncology; Organization; Systematic reviews

Indexed keywords

EID: 84939618891     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.22.2482     Document Type: Review

References (40)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynecological cancer. In: Preedy VR, Watson RR, eds. Handbook of Disease Burdens and Quality of Life Measures. New York, NY: Springer; 2010: 803–23.
2. Luesley D. Improving outcomes in gynaecological cancers. BJOG 2000;107:1061–3.
3. Marth C, Hiebl S, Oberaigner W, Winter R, Leodolter S, Sevelda P. Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology. Int J Gynecol Cancer 2009;19:94–102.
4. Lipscomb J. Transcending the volume–outcome relationship in cancer care. J Natl Cancer Inst 2006;98:151–4.
5. Geomini P, Kruitwagen RF, Bremer GL, Massuger L, Mol BW. Should we centralise care for the patient suspected of having ovarian malignancy? Gynecol Oncol 2011;122:95–9.
6. Olaitan A, McCormack M. Centralization of services for the management of ovarian cancer: arguments for. BJOG 2007:1188–90.
7. Crawford SM, Brunskill PJ. Centralisation of services for the management of ovarian cancer: arguments against. BJOG 2007;114:1183–5.
8. Elit L, Schultz S, Prysbysz R, et al. Patterns of care in the initial management of women with ovarian cancer in Ontario. Eur J Gynaecol Oncol 2009;30:361–4.
9. Elit L, Schultz S, Prysbysz R, et al. Patterns of surgical care for uterine cancers in Ontario. Eur J Gynaecol Oncol 2009;30:255–8.
10. Brouwers M, Kho ME, Browman GP, et al. on behalf of agree Next Steps Consortium. agree ii: advancing guideline development, reporting and evaluation in healthcare. CMAJ 2010;182:E839–42.
11. Shea BJ, Grimshaw JM, Wells GA, et al. Development of amstar: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.
12. Vernooij F, Heintz APM, Coebergh JW, et al. Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 2009;112:455–61.
13. United Kingdom, Department of Health, National Health Service. Guidance on Commissioning Cancer Services: Improving Outcomes in Gynaecological Cancers – The Manual. Wetherby, U.K.: Department of Health; 1999.
14. National Health Service Centre for Reviews and Dissemination. Management of gynaecological cancers. Eff Health Care 1999;5:1–12.
15. du Bois A, Rochon J, Pfisterer J, Hoskins WJ. Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 2009;112:422–36.
16. Giede KC, Kieser K, Dodge J, Rosen B. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol 2005;99:447–61.
17. Woo YL, Kyrgiou M, Bryant A, Everett T, Dickinson HO. Centralisation of services for gynaecological cancers—a Cochrane systematic review. Gynecol Oncol 2012;126:286–90.
18. Paulsen T, Szczesny W, Kaern J, Vistad I, Tropé C. Improved 8-year survival for patients with stage iiic ovarian cancer operated on at teaching hospitals: population-based study in Norway 2002. Clin Ovarian Cancer Other Gynecol Cancer 2012;5:60–6.
19. Münstedt K, von Georgi R, Misselwitz B, Zygmunt M, Stillger R, Künzel W. Centralizing surgery for gynecologic oncology? —a strategy assuring better quality treatment? Gynecol Oncol 2003;89:4–8.
20. Macdonald OK, Sause WT, Lee RJ, Dodson MK, Zempolich K, Gaffney DK. Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium? Gynecol Oncol 2005;99:730–5.
21. Elit LM, Bondy SJ, Paszat LP, et al. Surgical outcomes in women with ovarian cancer. Can J Surg 2008;51:346–54.
22. Kwon JS, Carey MS, Cook EF, Qiu F, Paszat LF. Are there regional differences in gynecologic cancer outcomes in the context of a single-payer, publicly-funded health care system? A population-based study. Can J Public Health 2008;99:221–6.
23. Brookfield KF, Cheung MC, Yang R, Byrne MM, Koniaris LG. Will patients benefit from regionalization of gynecologic cancer care? PLoS One 2009;4:e4049.
24. Kumpulainen S, Sankila R, Leminen A, et al. The effect of hospital operative volume, residual tumor and firstl i ne chemotherapy on survival of ovarian cancer—a prospective nation-wide study in Finland. Gynecol Oncol 2009;115:199–203.
25. Rachet B, Maringe C, Nur U, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the nhs cancer plan for England. Lancet Oncol 2009;10:351–69.
26. Vernooij F, Witteveen PO, Verweij E, van der Graaf Y, Heintz AP. The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients. Gynecol Oncol 2009;115:343–8.
27. Bristow RE, Palis BE, Chi DS, Cliby WA. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010;118:262–7.
28. Mercado C, Zingmond D, Karlan BY, et al. Quality of care in advanced ovarian cancer: the importance of provider specialty. Gynecol Oncol 2010;117:18–22.
29. Chan JK, Sherman AE, Kapp DS, et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol 2011;29:832–8.
30. Fago-Olsen CL, Høgdall C, Kehlet H, Christensen IJ, Ottesen B. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey. Acta Obstet Gynecol Scand 2011;90:273–9.
31. Yap JK, Baker LJ, Balega JZ, Chan KK, Luesley DM. Impact of improving outcome guidance in gynaecological cancer on squamous cell carcinoma of the vulva in the West Midlands, UK. J Obstet Gynaecol 2011;31:754–8.
32. Crawford R, Greenberg D. Improvements in survival of gynaecological cancer in the Anglia region of England: are these an effect of centralisation of care and use of multidisciplinary management? BJOG 2012;119:160–5.
33. Pecorelli S. Revised figo staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105:103– 4. [Erratum in: Int J Gynaecol Obstet 2010;108:176]
34. Rhodes CA, Cummins C, Shafi MI. The management of squamous cell vulval cancer: a population based retrospective study of 411 cases. Br J Obstet Gynaecol 1998;105:200–5.
35. Ismiil N, Ghorab Z, Nofech-Mozes S, et al. Intraoperative consultation in gynecologic pathology: a 6-year audit at a tertiary care medical center. Int J Gynecol Cancer 2009;19:152–7.
36. Brun JL, Cortez A, Rouzier R, et al. Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors. Am J Obstet Gynecol 2008;199:244.e1–7.
37. Bige O, Demir A, Saygili U, Gode F, Uslu T, Koyuncuoglu M. Frozen section diagnoses of 578 ovarian tumors made by pathologists with and without expertise on gynecologic pathology. Gynecol Oncol 2011;123:43–6.
38. Stewart CJ, Brennan BA, Hammond IG, Leung YC, McCartney AJ. Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases. Int J Gynecol Pathol 2006;25:216–22.
39. Le T, Giede C, Salem S, et al. on behalf of the Society of Obstetricians and Gynaecologists of Canada. Initial evaluation and referral guidelines for management of pelvic/ovarian masses. J Obstet Gynaecol Can 2009;31:668–80.
40. Fung-Kee-Fung M, Kennedy EB, Biagi J, et al. An organizational guideline for gynecologic oncology services. Int J Gynecol Cancer 2015;25:551–8.